A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

According to Guardant’s website, Medicare Part B (Medical Insurance) covers a blood-based biomarker screening test to check for colorectal cancer if the individual is between the ages of 45–85, shows ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

This provocative study demonstrates that biological age, which can be evaluated by a blood test, is associated with a higher ...

including advancing the second generation of its lead asset the ColoSTAT bowel cancer screening blood test. ColoSTAT detects ...

Improvements in cancer prevention and screening have averted more deaths than treatment advances over the past 45 years.

The rise in colorectal cancer among young people is a “global phenomenon,” according to a new study. While the increase in the number of Americans under 50 being diagnosed with the disease has ...

America's ultraprocessed diet may be a key culprit behind rising colon cancer rates in younger adults, a new study suggests. The study in the journal Gut found higher levels of inflammation in ...

For schools with more than 100 test-takers, the complete rankings are: Ateneo de Manila University (96.02%, 169/176) University of the Philippines (90.51%, 229/253) San Beda University (89.73% ...